NCT07450040: Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma

Sponsor: Eye & ENT Hospital of Fudan University. Phase: . Conditions: ORR, OS, PFS